Company Filing History:
Years Active: 2014-2016
Title: Bracken M King: Innovator in Cytokine Research
Introduction
Bracken M King is a notable inventor based in Boston, MA (US). He has made significant contributions to the field of cytokine research, holding 2 patents that focus on innovative approaches to modulating cellular signaling.
Latest Patents
His latest patents include "Nucleic acid encoding chimeric IL-1 receptor type I antagonists." This invention features non-naturally occurring cytokine domains that can be utilized to modulate cellular signaling responsive to interleukin-1 receptor I (IL-1RI). These advancements aim to treat various disorders and enhance the detection and binding to cellular receptors. The exemplary cytokine domains can incorporate amino acid residues from at least two parental cytokine domains, showcasing receptor binding features, surface features, β strands, and loops.
Another significant patent is "Chimeric IL-1 receptor type I antagonists," which shares similar characteristics and applications as the previous patent. This work further emphasizes the potential of cytokine domains in therapeutic and diagnostic applications.
Career Highlights
Bracken has worked with several prominent companies in the biotechnology sector, including Eleven Biotherapeutics, Inc. and Buzzard Pharmaceuticals. His experience in these organizations has contributed to his expertise in cytokine research and development.
Collaborations
Throughout his career, Bracken has collaborated with notable professionals, including Thomas M Barnes and Jinzhao Hou. These partnerships have likely enriched his research and innovation efforts.
Conclusion
Bracken M King is a distinguished inventor whose work in cytokine research has the potential to impact medical treatments significantly. His patents reflect a commitment to advancing the understanding and application of cytokine domains in therapeutic contexts.